BNP Paribas Discount Zert MRNA 27.../ DE000PN53VV7 /
24/05/2024 21:40:21 | Chg.+0.070 | Bid21:59:31 | Ask21:59:31 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
127.540EUR | +0.05% | 127.540 Bid Size: 500 |
127.590 Ask Size: 500 |
Moderna Inc | - USD | 27/06/2024 | Call |
GlobeNewswire
22/05
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
12/05
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
08/05
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/05
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
01/05
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire
01/05
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire
04/04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
GlobeNewswire
04/03
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024